DawMed Systems PLC
03 January 2006
DAWMED
For Immediate Release:
DAWMED SYSTEMS PLC
Director's Shareholdings
On 30 December 2005 Kevin Gilmore, the Chairman of the Company sold 1,000,000
Ordinary Shares of 5p each to his Self Invested Personal Pension scheme, the
trustees of which are Scottish Equitable plc, at 19p per share. Notwithstanding
the transfer of shares, Kevin Gilmore's underlying interest in the share capital
of the Company remains the same as it was before such transfer.
As a result of this transfer, the Company has received notices pursuant to
Sections 198 and 324 of the Companies Act 1985 from the following directors and
other shareholders in the Company as follows:
Number of
Ordinary Shares
Kevin M Gilmore
Shares 2,425,310 Ordinary Shares of 5p
each
Option 100,000 Ordinary Shares of 5p
each
Scottish Equitable plc (as trustee of
the Scottish Equitable Retirement
Control SIPP 4400913) 1,615,650 Ordinary Shares of 5p
each
Maryke L Gilmore (wife of Kevin M
Gilmore)
Shares 3,306,240 Ordinary Shares of 5p
-------- each
7,447,200
--------
Representing in aggregate 36.39% of the Company's issued share capital.
3 January 2006
Enquiries: Kevin Gilmore
Executive Chairman
DawMed Systems plc 01789 740010
Roland Cornish
Chairman
Beaumont Cornish Limited 020 7628 3396
Maxine Barnes/Dominic Barretto
Bishopsgate Communications Limited 020 7430 1600
This information is provided by RNS
The company news service from the London Stock Exchange
FKEFE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.